Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2025 | Story André Damons | Photo Supplied
Prof Wynand Goosen
Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards.

Being nominated for a ‘Science Oscar’ is exciting and validates nominees’ efforts, particularly in a field as challenging and essential as infectious diseases, for which they are recognised at the highest level. 

This is according to Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State (UFS). He was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards for his landmark discovery of Mycobacterium bovis infection in humans in South Africa – the first confirmed cases in the country. 

Prof Goosen, who previously won the NSTF-South32 Emerging Researcher Award, says the nomination is a powerful affirmation of the impact that focused, interdisciplinary research can have. It reflects not only his personal commitment but also the dedication of a talented and hard-working team. “I am honoured and humbled to be nominated. It is also a testament to the support and vision of UFS, particularly as we position ourselves as leaders in One Health research in South Africa,” he says. 

 

Focus of research 

He was nominated by Prof Vasu Reddy, UFS Deputy Vice-Chancellor: Research and Internationalisation, and Prof Paul Oberholster, Dean for the Faculty of Natural and Agricultural Sciences (NAS) at the UFS, and Prof Nico Gey van Pittius and Prof Elmi Muller from Stellenbosch University (US). The NSTF Awards, known as the ‘Science Oscars’of SA, honour, reward, celebrate, profile and promote outstanding contributions to science, engineering and technology (SET) and innovation in South Africa.

“The nomination,” Prof Goosen continues, “recognises our work in the field of zoonotic tuberculosis (TB) and other emerging infectious diseases at the human-animal-environment interface. Our research focuses on the molecular detection and characterisation of pathogenic mycobacteria in wildlife, livestock, and human populations, with the aim of informing better surveillance, diagnostics, and control strategies — particularly in high-risk ecosystems. This includes novel applications in wildlife TB surveillance and understanding the transmission dynamics between animals and people.”

 

Establishing a Kovsie One Health Research Unit

This research is critically important as South Africa continues to face a high burden of tuberculosis, including zoonotic TB, which often goes under-detected in rural and wildlife-rich areas. Understanding how these pathogens circulate between humans, animals, and the environment, explains Prof Goosen, is essential for effective disease control and to mitigate future pandemics. This work directly supports national health priorities, informs policy, and contributes to global strategies for One Health.

Prof Goosen and the team are in the process of laying the groundwork for the establishment of a Kovsie One Health Research Unit, which will serve as a collaborative platform for research spanning human, animal, and environmental health. One of their key projects involves expanding TB and AMR surveillance in wildlife-livestock-human interfaces, using cutting-edge diagnostics and genomic tools. They are also initiating partnerships with industry and international institutions to address emerging zoonoses and environmental pathogens in a transdisciplinary manner.

News Archive

UFS academics to present papers at Conference on Calvin Research
2010-07-05

Prof. Dolf Britz, Director: Jonathan Edwards Center Africa at the UFS, will be one of three UFS keynote speakers at the 10th International Congress on Calvin Research.
Photo: Provided


Three scholars from the University of the Free State (UFS) were invited to participate as keynote speakers at the 10th International Conference on Calvin Research that will be hosted by the UFS from 22-27 August 2010. 

“Hosting this conference is seen as an exceptional achievement since the conference represents an international, high-profiled and specialised research community where invitation to present research results is based on proven academic outputs, innovation and original research,” said Prof. Dolf Britz, Director: Jonathan Edwards Center Africa at the UFS. Prof. Britz will, as keynote speaker, present a paper on Calvin's exposition of a Biblical text that played a significant role in the ‘Freedom Struggle’ in South Africa.

The programme for the Conference on Calvin Research also provides for two workshops specially designed for postgraduate students. This will be facilitated by international scholars and the focus will be on research methodology and the academic competencies to write a dissertation.

A student from the UFS, Rev. Ntabanyane Tseuao, was selected to present a short paper at the conference. He is one of three postgraduate students who are from the Theological University Apeldoorn in the Netherlands and the University of Tübingen in Germany, respectively.

Prof. Erik de Boer, an Extraordinary Professor and Research Fellow at the UFS and Mr Eric Kayayan, a Research Fellow at the UFS, will also be keynote speakers at the conference.

Two other academics from the UFS, Prof. Adriaan Neele, an Extraordinary Professor and Research Fellow and Dr Victor d’Assonville, a Research Fellow, will also present papers.

The participation of these academics in the conference is the result of an initiative that started eight years ago to cluster South African research on Classical and Reformation Theology at the University of the Free State. - Leonie Bolleurs

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept